Find in Library

Second generation of temporary implantable nitinol device (iTind) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study

oleh: G. Kadner, M. Valerio, I. Giannakis, M. Arya, N. Lumen, B.S. Ho, S. Alonso, C. Schulman, N. Barber, D. Amparore, F. Porpigila